FiercePharma20d
Kindeva unit Meridian Medical snares $129M to supply US with nerve agent antidote
Meridian Medical Technologies, a unit of CDMO Kindeva, snared a $129 million contract to supply the United States with the chemical nerve agent antidote autoinjector DuoDote. The FDA-approved ...
The American Journal of Managed Care21d
Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression
Esketamine is the first monotherapy for MDD with inadequate response to two oral antidepressants, approved after a priority FDA review. Clinical trials showed esketamine's rapid efficacy, with 22. ...
verywellhealth21d
Injectable Alzheimer's Drugs Could Save Patients Trips to the Hospital
If approved, the injectable version would come packaged in an autoinjector device that allows a person to administer a shot themselves, rather than rely on a healthcare provider. The injection process ...
WRIC25d
Aktiv Medical Entered Autoinjector Development Partnership for Large-Dose Volume / High-Concentration Injection
The product will benefit from Aktiv’s proprietary PenPal gas-driven autoinjector platform including ultra high-performance reliability and unique capabilities to accommodate any standard glass ...
Healio27d
FDA accepts BLA for Leqembi subcutaneous autoinjector maintenance dosing
The FDA has accepted Eisai and Biogen’s biologics license application for a subcutaneous autoinjector weekly maintenance dose of Leqembi for patients with mild cognitive impairment or mild ...
USA Today27d
Auto Fire breaks out in Ventura, California burning just outside LA: See map
While Los Angeles County continues to grapple with a deadly outbreak of wildfires, a new blaze broke out in neighboring Ventura County Monday night. The Auto Fire has burned nearly 61 acres in ...
Yahoo Finance28d
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
On Monday, the FDA accepted Eisai Co., Ltd. (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) Biologics License Application (BLA) for lecanemab-irmb (Leqembi) subcutaneous autoinjector (SC-AI ...
Benzinga.com28d
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
FDA sets August 31, 2025, as the action date for Eisai and Biogen's Leqembi subcutaneous autoinjector application. Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly ...
Nasdaq28d
Eisai and Biogen Announce FDA Acceptance of Lecanemab Subcutaneous Autoinjector Application for Alzheimer's Disease Treatment
If LEQEMBI subcutaneous maintenance dosing is approved by the FDA, LEQEMBI will be the only treatment for AD that can be administered subcutaneously at home using an autoinjector (AI). The ...
The New York Times28d
Auto Fire Joins List of California Blazes
The new fire, in Ventura County northwest of Los Angeles, covers 56 acres and is 0 percent contained, officials said. By Victor Mather Firefighters are tracking a new blaze in Southern California ...
Managed Healthcare Executive28d
FDA Accepts BLA for Leqembi Autoinjector
If approved, subcutaneous autoinjector Leqembi will be the only Alzheimer's medication that can be administered at home. The FDA has set a goal date of Aug. 31, 2025. The FDA has accepted a biologics ...